Ani Pharmaceuticals (ANIP) Cash from Discontinued Operations (2012 - 2013)
Ani Pharmaceuticals' (ANIP) quarterly Cash from Discontinued Operations came in at 44000.0 in Q4 2013, down 72.15% year-on-year from 158000.0 in Q4 2012, and up 118.75% quarter-over-quarter from 234624.0 in Q3 2013.
Ani Pharmaceuticals (ANIP) Cash from Discontinued Operations (2012 - 2013) Analysis & Trends
Ani Pharmaceuticals has disclosed Cash from Discontinued Operations across 2 years of filings, most recently posting 44000.0 for Q4 2013.
- Cash from Discontinued Operations for Q4 2013 came in at 44000.0, down 72.15% year-over-year; the trailing twelve-month figure through Dec 2014 was 32624.0 (up 88.43% YoY), and the FY2013 annual result was 195000.0, down 37.32% from the prior year.
- Cash from Discontinued Operations came in at 44000.0 for Q4 2013 at Ani Pharmaceuticals, up from 234624.0 in the prior quarter.
- In the past five years, Cash from Discontinued Operations ranged from a high of 158000.0 in Q4 2012 to a low of 249446.0 in Q3 2012.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Ani Pharmaceuticals | 1.71 Bn | 1.40 Bn | 143.88 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2013 | 44,000.00 |
| Dec 31, 2013 | 44,000.00 |
| Sep 30, 2013 | -234,624.00 |
| Sep 30, 2013 | -234,624.00 |
| Dec 31, 2012 | 158,000.00 |
| Dec 31, 2012 | 158,000.00 |
| Sep 30, 2012 | -249,446.00 |
| Sep 30, 2012 | -249,446.00 |